Thyrocare Expands Reach with Polo Labs Acquisition

Healthcare conglomerate Thyrocare has announced the acquisition of the pathology diagnostic division of Polo Labs. This strategic maneuver is designed to amplify Thyrocare’s influence within the northern region of India.

A History of Growth and Investment

Thyrocare, which was acquired by API Holdings in 2021 for a substantial $613 million, has secured a cumulative investment of $63.6 million to date. The company is renowned for its automated diagnostic laboratories and commitment to delivering affordable, high-quality reports to healthcare institutions both domestically and internationally.

Polo Labs: A Regional Player

Polo Labs, a prominent pathology laboratory operating across Punjab, Haryana, Himachal Pradesh, and Jammu & Kashmir, has earned a reputation for providing accessible and cost-effective diagnostic services. The laboratory’s infrastructure, equipped with modern technology, ensures the delivery of exceptional results that meet and exceed customer expectations.

Synergistic Expansion

Thyrocare’s administration accepts the procurement of Polo Labs adjusts consistently with the organization’s more extensive vital goals. By incorporating Polo Labs’ activities, Thyrocare plans to improve its analytic capacities and grow its geological impression across India.

A Visionary Founder

Founded by the visionary Arokiaswamy Velumani, Thyrocare has established a formidable presence in over 2,000 cities worldwide. The company’s unwavering dedication to quality and affordability has been instrumental in its success.